siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice.

MLA

Ding, Yi, et al. “SiRNA Nanoparticle Targeting Usp20 Lowers Lipid Levels and Ameliorates Metabolic Syndrome in Mice.” Journal of Lipid Research, vol. 65, no. 9, Sept. 2024, p. 100626. EBSCOhost, https://doi.org/10.1016/j.jlr.2024.100626.

APA

Ding, Y., Chen, Q.-B., Xu, H., Adi, D., Ding, Y.-W., Luo, W.-J., Zhu, W.-Z., Xu, J.-C., Zhao, X., Shi, X.-J., Luo, J., Yin, H., & Lu, X.-Y. (2024). siRNA nanoparticle targeting Usp20 lowers lipid levels and ameliorates metabolic syndrome in mice. Journal of Lipid Research, 65(9), 100626. https://doi.org/10.1016/j.jlr.2024.100626

Chicago

Ding, Yi, Qiu-Bing Chen, Hui Xu, Dilare Adi, Yi-Wen Ding, Wen-Jun Luo, Wen-Zhuo Zhu, et al. 2024. “SiRNA Nanoparticle Targeting Usp20 Lowers Lipid Levels and Ameliorates Metabolic Syndrome in Mice.” Journal of Lipid Research 65 (9): 100626. doi:10.1016/j.jlr.2024.100626.